182 related articles for article (PubMed ID: 36274054)
1. Circulating LncRNAs landscape as potential biomarkers in breast cancer.
Pourramezan Z; Attar FA; Yusefpour M; Azizi M; Oloomi M
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1722. PubMed ID: 36274054
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs as novel prognostic biomarkers for breast cancer in Egyptian women.
El-Helkan B; Emam M; Mohanad M; Fathy S; Zekri AR; Ahmed OS
Sci Rep; 2022 Nov; 12(1):19498. PubMed ID: 36376369
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA SPRY4-IT1 is a prognostic factor for poor overall survival and has an oncogenic role in glioma.
Zhou Y; Wang DL; Pang Q
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3035-9. PubMed ID: 27460732
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling revealed up-regulation of three lncRNAs in breast cancer samples.
Mohebi M; Sattari A; Ghafouri-Fard S; Modarressi MH; Kholghi-Oskooei V; Taheri M
Exp Mol Pathol; 2020 Dec; 117():104544. PubMed ID: 32976818
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of SPRY4-IT1 in efficacy and survival prediction in breast cancer patients undergoing neoadjuvant chemotherapy.
Zheng A; Zhang L; Song X; Jin F
Histol Histopathol; 2020 Apr; 35(4):361-370. PubMed ID: 31638266
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
[TBL] [Abstract][Full Text] [Related]
8. A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma.
Huang J; Zheng Y; Xiao X; Liu C; Lin J; Zheng S; Yang B; Ou Q
Dis Markers; 2020; 2020():5417598. PubMed ID: 32733618
[TBL] [Abstract][Full Text] [Related]
9. The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression.
Shi Y; Li J; Liu Y; Ding J; Fan Y; Tian Y; Wang L; Lian Y; Wang K; Shu Y
Mol Cancer; 2015 Feb; 14():51. PubMed ID: 25742952
[TBL] [Abstract][Full Text] [Related]
10. Sex-specific up-regulation of lncRNAs in peripheral blood of patients with schizophrenia.
Fallah H; Azari I; Neishabouri SM; Oskooei VK; Taheri M; Ghafouri-Fard S
Sci Rep; 2019 Sep; 9(1):12737. PubMed ID: 31484957
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA SPRY4-IT1 Can Predict Unfavorable Prognosis and Lymph Node Metastasis: a Meta-Analysis.
Li N; Tan Q; Jing W; Luo P; Tu J
Pathol Oncol Res; 2017 Oct; 23(4):731-736. PubMed ID: 28054316
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of the long non-coding RNA, SPRY4 Intronic Transcript 1, in patients with cancer: a meta-analysis.
Wang M; Dong X; Feng Y; Sun H; Shan N; Lu T
Oncotarget; 2017 May; 8(20):33713-33724. PubMed ID: 28410241
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
Peng W; Wu G; Fan H; Wu J; Feng J
Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
[TBL] [Abstract][Full Text] [Related]
14. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of long noncoding RNA Z38 as a candidate biomarker in breast cancer.
Nie ZL; Wang YS; Mei YP; Lin X; Zhang GX; Sun HL; Wang YL; Xia YX; Wang SK
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28247935
[TBL] [Abstract][Full Text] [Related]
16. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX
Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of SPRY4-IT1 in female breast carcinoma and malignant tumors of the reproductive system: A meta-analysis.
Qin X; Yin Q; Gao J; Shi X; Tang J; Hao L; Li P; Zhu J; Wang Y
Medicine (Baltimore); 2022 Apr; 101(16):e28969. PubMed ID: 35482980
[TBL] [Abstract][Full Text] [Related]
18. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis.
Gao S; Zhao ZY; Wu R; Zhang Y; Zhang ZY
Onco Targets Ther; 2018; 11():4877-4891. PubMed ID: 30147339
[TBL] [Abstract][Full Text] [Related]
20. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
Xie M; Nie FQ; Sun M; Xia R; Liu YW; Zhou P; De W; Liu XH
J Transl Med; 2015 Aug; 13():250. PubMed ID: 26238992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
